Shares slipped in New York and Europe Thursday as the latest US inflation report strengthened the case for a slower pace of ...

The FTSE 100 index traded up 25.77 points, 0.3%, at 8,269.51. The FTSE 250 slipped 12.69 points, 0.1%, at 20,809.69, and the AIM All-Share down just 0.19 of a point at 736.47.

Chinese stock markets returned to winning ways Thursday, closing with solid gains after China's central bank took action to ...

There are just six months left to fill any gaps in your national insurance records (going back as far as 2006) if you want to ...

The idea is that if you move your focus to attracting people, you’ll ultimately attract the companies: If you build it (the ...

Sam Williamson, from Glossop, faces being taken to court by Northern Rail after he was caught out by an obscure rule on his railcard. Read this and the rest of today's consumer and personal finance ...

We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...

Oct 8 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in its third season after patients ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines.

GSK GSK3.22%increase; green up pointing triangle agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine ...

Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US as Millions Fewer People Line Up By Michael Erman (Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after ...